Patents Assigned to Cresilon, Inc.
  • Patent number: 12016968
    Abstract: The invention relates to biocompatible polymer gel compositions useful in facilitating and maintaining hemostasis. The biocompatible polymeric gel composition is comprised of (a) one or more than one polyanionic polymer, (b) one or more than one polycationic polymer, and (c) a solvent. A preferred composition includes sodium alginate, chitosan, and water to produce an adhesive hemostatic device that is useful in facilitating and maintaining rapid hemostasis.
    Type: Grant
    Filed: December 23, 2020
    Date of Patent: June 25, 2024
    Assignee: Cresilon, Inc.
    Inventors: Joseph A. Landolina, Omar M. Ahmad
  • Patent number: 11383005
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: July 12, 2022
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • Patent number: 10850003
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: December 1, 2020
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • Patent number: 9687584
    Abstract: A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked the surface of the wound and 2) one or more polycationic polymers such as chitosan or DEAE-Dextran, that assists in the solidification process as well as speeds up hemostasis without the need for applying pressure. The biocompatible polymeric composition may further comprise a cross-linking agent such as aqueous calcium chloride. The invention encompasses an initial polymeric composition, the solidified matrix cross-linked and integrated at the wound site, including the methods of using, applying, and cross-linking the composition.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: June 27, 2017
    Assignee: Cresilon, Inc.
    Inventor: Joseph A. Landolina
  • Patent number: D909570
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: February 2, 2021
    Assignee: CRESILON, INC.
    Inventors: Omar Ahmad, Jonathan Lee, Matthew Swift, Joseph Landolina